Galectins constitute a family of evolutionarily conserved animal lectins, which are defined by their affinity for poly-Nacetyllactosamine-enriched glycoconjugates and sequence similarities in the carbohydrate recognition domain. During the past decade, attempts to dissect the functional role for galectins in vivo have been unsuccessful in comparison to the overwhelming information reached at the biochemical and molecular levels. The present review deals with the latest advances in galectin research and is aimed at validating the functional significance of these carbohydrate-binding proteins. Novel implications of galectins in cell adhesion, cell growth regulation, immunomodulation, apoptosis, inflammation, embryogenesis, metastasis and pre-mRNA splicing will be particularly discussed in a trip from the gene to the clinical therapy. Elucidation of the molecular mechanisms involved in galectin functions will certainly open new avenues not only in biomedical research, but also at the level of disease diagnosis and clinical intervention, attempting to delineate new therapeutic strategies in autoimmune diseases, inflammatory processes, allergic reactions and tumor spreading.
A biochemical and molecular overview: passport required to galectin research
Galectins are an enigmatic family of evolutionarily conserved proteins widely distributed in nature from lower invertebrates to mammals. 1 ± 3 They share sequence similarities in the carbohydrate recognition domain (CRD) in addition to specificity for N-Acetyllactosamine-enriched glycoconjugates. 1, 2 The typical carbohydrate-binding domain consists of 135 amino acids tightly folded into a sandwich structure of 5 ± 6-stranded b-sheets and recognizes the basic structure of LacNAc; (Gal b1?4GlcNAc). 3 Ten mammalian galectins have so far been identified in a wide variety of tissues of several species. 4 Although this new systematic classification of galectins from 1 to 10 is not extrapolable to non-mammalian galectins, the latter share striking similarities with mammalian galectins at the molecular level. According to their architecture, Hirabayashi and Kasai 5 classified this protein family into proto-type, chimera type and tandem-repeat type. Proto-type galectins, include galectins-1, 6,7 -2, 8 -5, 9 -7, 10 human Charcot-Leyden crystal protein, 11 frog galectins, 12 electrolectin (the first galectin described); 13 C. elegans 16 kDa galectin, 14 chicken isolectins C-14 and C-16 15, 16 and marine sponge galectins. 17 Proto-type galectins are non-covalent homodimers composed of two identical CRDs. The best studied among them, galectin-1, formerly referred to as L-14, galaptin and BHL among other names, has been localized in skeletal, smooth and cardiac muscle, motor and sensory neurons, thymus, kidney and placenta. 4 On the other hand, chimera-type galectins show a combined structure composed of a carboxy terminal CRD linked to a proline-, glycine-, and tyrosine-rich N-terminal domain. The only member of this family, galectin-3 (previously known as Mac-2, L-29, CBP-35 or IgEBP), has been predominantly found in mammals, 18 although it has been also identified in chickens. 19 It has been shown to be expressed by activated macrophages, basophils, mast cells and certain epithelial and tumor cells. 18 The third family of tandem-repeat galectins are proteins with two distinct CRDs and includes galectins-4, 20 -6, 21 - 8 22 and -9. 23 Several galectin genes have been cloned and characterized and found to be associated to multiple regulatory elements.
Studies of multiple animal lectins including galectins-1 and -2, by X-ray crystallography, have provided evidence for their oligomeric structures. 24, 25 By virtue of their multivalency, these carbohydrate-binding proteins are able to cross-link specific glycoprotein and glycolipid receptors, leading to activation of different signal transduction pathways, which converge in multiple biological responses.
screening tumor cDNA libraries with sera from tumorbearing patients. 23 Regulation of galectin expression, subcellular distribution and secretion: a dilemma to be solved
Galectins have been proposed to play crucial roles by recognizing carbohydrate moieties on intracellular ligands, cell signaling receptors and extracellular glycoproteins, according to subcellular compartamentalization, developmentally regulated expression and cell activation status. 28 Expression of galectins was found to be up-or downregulated during embryogenesis, being a typical hallmark of specific developmental stages. 29 Moreover, galectin expression and subcellular distribution have been reported to be highly susceptible to modulation by diverse stimuli such as sodium butyrate, 30 viral infections, 31 tumor suppressor genes 32 or inflammatory agents. 33 In this review, we will discuss in detail the regulated expression of RMGal, a macrophage galectin-1-like protein, isolated and characterized in our laboratory, which showed immunomodulatory properties. 27, 34 What is the molecular mechanism involved in this regulated expression? Although this question warrants further investigation, a recent study revealed some clues. Gillenwater and colleagues 30 demonstrated that sodium butyrate, a known differentiating agent was able to modulate galectin-1 content in human head and neck squamous carcinoma cells by a combination of transcriptional regulation and inhibition of histone deacetylation.
Regarding galectin secretion, some critical points must be addressed. From the viewpoint of protein structure, galectins have been designed as proteins intended to play key roles inside the cells; e.g., acetylated N-terminus, lack of secretion signal peptide and biosynthesis on free ribosomes. 3, 28 Indeed, novel intracellular functions have been reported for galectins in the last few years, such as pre-mRNA processing. 35 However, most of the functions assigned to b-galactoside-binding proteins are confined to the cell surface or extracellular milieu. 28 An evolutionary explanation of this picture could be raised by speculating that galectins acquired extracellular functions in the course of the development of multicellular metazoan organisms, but their original tasks were confined to intracellular environments in primitive organisms. 4 Nevertheless, the mechanism by which these cytosolic proteins are targeted to subcellular compartments and exported to the extracellular space still remains to be elucidated. Concerning the externalization of galectin-1, two hypothesis have been proposed. One likely explanation is the utilization of specific transmembrane carriers, like those used to export some bacterial toxins. 36 The second hypothesis considers the possibility that galectin-1 could be secreted by a novel apocrine mechanism, in which the synthesized protein becomes concentrated at the level of plasma membrane evaginations prior to secretion and further externalized to form galectin-enriched extracellular vesicles. 28 Recently, Mehul and Hughes 37 demonstrated that the rate-limiting step for galectin-3 secretion is the trafficking from biosynthetic sites to the plasma membrane and that the signal for secretion lies in the N-terminal domain of the lectin. Furthermore, they provided evidence that galectin-3 is externalized in vesicles and released into the extracellular medium. A kind of unfrequent mechanism of externalization is also used by many cytokines and growth factors. 38 Galectins can be targeted and secreted to exert their functions by interacting with intracellular and extracellular glycoconjugates. Subcellular targetting of these proteins to different intracellular compartments was found to be an additional level of modulation by diverse stimuli. Translocation of galectin-3 to the nucleus was evident when quiescent fibroblasts were exposed to growth factors. 39 Moreover, its secretion was induced in activated but not in resident macrophages. 33 Unraveling the puzzle of galectin functions: the main stop of the trip! Attempts to dissect the functional roles for galectins in vivo have been unsuccessful in comparison to the overwhelming information reached at the biochemical and molecular levels. Targeted disruption of galectin-1 and -3 genes in single or double knock out mice resulted in the absence of major phenotypic abnormalities, 40, 41 suggesting that other members of this family could potentially compensate for the absence of these proteins, as suggested for null mutations in particularly important genes. Nevertheless, their conservation throughout animal evolution and their widespread distribution, strongly suggest they could be critical for life. Identification of novel pleiotropic functions for this protein family has attracted the attention of many investigators in the last few years, raising many exciting questions.
What is the functional need for creating multiple genes encoding galectins that seem to recognize broadly similar arrays of carbohydrate epitopes within each family? One likely explanation is related to differences in carbohydratebinding specificities, as has been established for several galectins. 4, 42 On the other hand, redundancy is often built into mechanisms operating in key events during development as a form of fail-safe insurance. 43 Galectins have been implicated in several physiopathological processes requiring carbohydrate recognition, such as cell adhesion, 28 cell growth regulation, 44, 45 immunomodulation, 46 ,47 apoptosis, 34, 48, 49 inflammation, 50 embryogenesis, 29 reproduction, 51, 52 tumor spreading 53, 54 and premRNA splicing. 35, 55 The precise knowledge of the mechanism of action of galectins is lacking, although their effects are believed to relate to interactions with specific carbohydrate ligands. It should be emphasized that the vast majority of galectin functions have been assigned to galectins-1 and -3. In contrast, functions corresponding to other members of this protein family are still a virgin land, and remain to be elucidated in future work. The present review deals with the latest advances in galectin research and is aimed at validating the concept of an in vivo role for this evolutionarily conserved protein family and its implications in biomedical research and clinical therapy.
Galectins in cell-cell, cell-matrix interactions: to stick or not to stick?
Adhesion and migration of cells through basement membranes and the extracellular matrix (ECM), is a multistep process coordinated by receptors recognizing a mosaic of ECM glycoproteins, haptotactic chemokines and pro-inflammatory cytokines. 56 In this context, galectins are secreted into the extracellular millieu, where they recognize poly-Nacetyllactosamine chains on major ECM components. 28 Consistently, a variety of extracellular and intracellular candidate ligands have been reported to bind galectins, such as laminin, 57 fibronectin, 58 lysosome-associated membrane proteins 1 and 2 (LAMP-1 and 2) 59 and CD45. 48 In view of this specific recognition, galectins have been postulated as powerful modulators of cell-cell and cell-ECM interactions. Controversial results have been reported as to whether galectin-1 exerts a positive or a negative effect on cell adhesion to ECM glycoconjugates, raising the possibility that this homodimeric protein could promote cell attachment or detachment according to the cell type or cell developmental stage. 28 The presence of galectin-1 inhibited myoblast interaction with laminin by sterically blocking the laminin receptor a 7 b 1 integrin from recognizing laminin, thus allowing myoblasts to fuse into myotubes. 60 Moreover, we have recently shown that galectin-1 specifically inhibited T cell adhesion to ECM glycoproteins. This effect correlated with the ability of this molecule to prevent the re-organization of the activated T cell's actin cytoskeleton. 61 On the other hand, galectin-1 showed pro-adhesive properties on other cell types, such as melanoma cell lines, 62 F9 murine embryonic teratocarcinoma cells, 57 olfactory neurons, 63 rhabdomyosarcoma cells 58 and CHO fibroblasts. 57 Interestingly, to exert these stimulatory effects, dimeric galectin-1 acted by bridging oligosaccharides between specific cell surface glycoconjugates and ECM components. Similarly, the effects of galectin-3 on cell adhesion were conflicting, depending on the physiopathological environment. While this chimeric protein promoted neutrophil adhesion to laminin in the context of an inflammatory response, 64 it showed a dramatic inhibitory effect on melanoma cell adhesion to ECM in a threatening situation of tumor spreading. 65 Hence, what is the biological significance whereby the same endogenous protein can exert completely opposite effects according to different physiopathological situations? Further investigations will be needed to clarify these findings.
Galectins in cell growth regulation: how to bias the equilibrium?
In multicellular organisms, homeostasis is maintained through a delicate balance between cell proliferation and cell death. 66 In addition to promoting or inhibiting cell attachment in the context of the ECM, galectins have been also reported to exert critical but contradictory effects on cell growth. A mitogenic effect towards vascular cells has been reported for galectin-1 during alveolarization of post-natal rat lung. 67 On the other hand, Wells and Mallucci 44 demonstrated that galectin-1 acted as a powerful autocrine cytostatic and negative growth factor in murine embryonic fibroblasts, by arresting the cell cycle at G0 and G2 check points. Implications of galectin-1 in cell growth arrest and apoptosis in the context of the immune system will be discussed in detail in the next section.
To reconcile these findings, an interesting activity of galectin-1 as a biphasic modulator of cell growth has been reported. 45 While this b-galactoside-binding protein was found to be mitogenic at low physiological concentrations, growth-inhibitory properties were apparent in a higher concentration range, when tested on human cells in vitro. Thus, the effects of galectin-1 seem to be double-edged, since it may trigger either proliferation or cell growth arrest, depending on the presence of concomitant environmental signals, dose, cell cycle stage, or the expression of carbohydrate receptors on the cell surface. 45 It should be highlighted that the concept of a bifunctional protein with both growth-stimulatory and growth-inhibitory activities is not limited to galectins. Other signaling molecules such as TGF-b 68 and FasL, 69 have been shown to trigger different effects depending on the type and functional state of the cell. Indeed, the interaction of positive and negative signals to maintain homeostasis is compatible with the basic yinyang principle of the universe.
Galectins in the immune system: the missing link?
Research over the past decade identified immunomodulatory properties for galectin-1 in the context of two experimental models of autoimmune disease. Administration of recombinant galectin-1 prevented clinical and histopathological signs of experimental encephalomyelitis (EAE), a T-cell-mediated autoimmune disease in susceptible Lewis rats. 47 Moreover, an homologous galectin from the fish Electrophorus electricus showed prophylactic and therapeutic effects on experimental autoimmune myasthenia gravis (EAMG) in rabbits. 46 Although the precise mechanisms involved in these properties in vivo still remain to be elucidated, it has been proposed that galectin-1 may affect processes in T-cell suppressor commitment and in sensitization or deletion of antigenspecific T cells. 46, 47 Particularly attractive, experimental data have been accumulated in the last few years, concerning the implications of galectin-1 in apoptosis of mature T cells 34, 48, 52 and immature cortical thymocytes. 70 It may also be relevant that autoantibodies against galectin-1 have been demonstrated in sera of patients with neurological disorders, particularly those suffering from multiple sclerosis. 71 The conceptual idea that a carbohydrate binding protein could affect the apoptotic threshold of T cells, not only provided a breakthrough in galectin research, but also revolutionized the field of glycoimmunology. Consequently, in the next section we will entirely concentrate on this novel function and its potential implications in health and disease.
The second evidence supporting the idea that these versatile proteins could be implicated in the regulation of adaptive immune responses comes from the striking localization of galectin-1 in immune privileged sites of the body, such as the placenta 6, 52 and the eye, 72 where multiple factors operate to ensure rapid elimination of inflammatory cells. T-cell apoptosis would hence provide a sophisticated, naturally occurring mechanism to confer protection to vulnerable sites from tissue damage. Recent studies have shown that expression of FasL in sites of immune privilege may have a key role in preserving this privilege by selectively killing activated T cells by apoptosis. 73 Accordingly, one might speculate that galectin-1 represents an alternative regulatory signal to regulate mechanisms operating in the establishment of immune privilege. Expression of this protein in first term gestation placenta, could be significant in protecting the fetus from the immune system of the mother by killing infiltrating T cells. 52 Moreover, galectin-1 expression in the context of the eye would protect this sensory organ from the devastating effects of an inflammatory response. 73, 74 In addition, a protein related to the galectin family called GRIFIN (galectin-related interfiber protein) was recently found in lens by cDNA display techniques. 72 These protein may contribute to the process whereby cells in the lens become apoptotic and filled with the clear protein, cristallin.
Galectin-1 has also been identified not only in peripheral lymphoid organs such as lymph nodes 75 and spleen, 27, 76 but also at the level of central thymic microenvironment, where thymocyte education takes place. 77 Human thymic epithelial cells synthesize galectin-1, which binds to oligosaccharide ligands on the surface of thymocytes. 77 The degree of galectin-1 binding to thymocytes correlated with the maturation stage of the cells, as immature thymocytes bound more galectin-1 than did mature thymocytes. This result suggests one mechanism for the influence of thymic epithelial cells in positive selection of thymocytes bearing the appropriate T-cell receptor and in negative selection of autoaggressive clones. Taken together, these observations strongly support the idea that galectins could be critical regulators in the generation, maintenance and restoration of central and peripheral immune tolerance.
In the last few years, new advances have extended the interface between glycobiology and immunology. Recently, using a mRNA display PCR to search for genes induced in activated T cells, galectin-1 gene expression was found to be strongly upregulated in effector T cells. 78 This protein was able to inhibit antigen-induced proliferation of naive and memory T cells, acting as an autocrine negative growth factor. When this inhibitory mechanism was investigated in detail, it was confirmed that galectin-1 switched off T lymphocyte effector functions, by arresting cell cycle progression at the level of the S and G 2 /M stages and alternatively triggering IFN-g-mediated apoptosis of activated human T lymphocytes. 79 In addition to the immunosuppressive and inhibitory functions reported here for galectin-1, recent studies have shown that galectin-3, formerly defined as an IgE-binding protein, was able to inhibit IL-5 gene transcription and protein release from human eosinophils and allergenspecific T cell lines. 80 The possibility to shut down the IL-5 pathway opens new avenues in the regulation of the T helper 2-dependent allergic reactions. Further investigations will be needed to clarify the mechanisms involved in this process. Finally, a recent study has also postulated a role for galectin-3 in early events of the immune response by optimizing cell-cell contact and antigen presentation between professional dendritic cells and naive lymphocytes. 81 Finally, a crucial question must be inevitably raised. Are galectins essential for the immune response to such a degree to be considered`the missing links', or are they mere`supporting actors', acting as redundant proteins? Undoubtedly, a main challenge for future work.
Galectins: a novel paradigm in the regulation of programmed cell death
The first clue indicating that a b-galactoside-binding protein could be associated with apoptosis was provided by Goldstone and Lavin in 1991, 82 who reported that the galectin-1 gene was overexpressed during glucocorticoid-induced cell death.
Apoptosis occurs in a wide variety of specific physiological situations and plays a crucial role in normal tissue homeostasis. 66, 83 Although diverse signals can induce apoptosis in a wide variety of cell types, a number of evolutionarily conserved genes regulate a final common cell death pathway that is preserved from worms to humans. 66, 74 Of particular relevance to the immune system, cell death programs promote tolerance by deletion of autoreactive lymphocytes in the central lymphoid organs and termination of immune responses in the peripheral immune system. Gene knock out experiments in mice have failed to identify unique receptors necessary for apoptosis in the thymus other than the T cell receptor and glucocorticoids. In the context of novel molecules involved in central death machinery, galectin-1 expressed by human thymic epithelial cells 77 has been recently shown to induce apoptosis of immature cortical thymocytes. 70 Two subpopulations were particularly susceptible to galectin-1-induced apoptosis: the first corresponding to non-selected thymocytes bearing the immature phenotype CD3 7 CD4 low CD8 low CD69 7 and the second corresponding to a negatively-selected population of CD3 int CD4 low CD8 low CD69 7 thymocytes. 70 Hence, galectin-1 is the ideal candidate to be second apoptotic signal required for TCRmediated negative selection. Vespa et al, 84 have recently demonstrated that galectin-1 specifically modulates TCR signals to enhance TCR-mediated apoptosis. The model of galectin-1 gene knock out mice 40 will be useful for the elucidation of the precise role of galectin-1 in the elimination of non-selected and negatively selected cells during thymocyte development.
T cells that emerge from the thymus contain not only a wide repertoire of foreign antigen receptor specificities, but also potentially autoaggresive clones that were not eliminated during central tolerance. 74 These potentially autoreactive clones are then subjected to peripheral tolerance. Activation-induced cell death of mature peripheral T cells is indeed one of the mechanisms aimed at the elimination of dominant autoagressive clones. 74, 85 Those clones may die by fratricide or suicide mediated by FasFasL or TNF-TNFR1 interactions. 74 In this context, galectin-1 has been also reported to induce apoptosis of mature T cells. 34, 48, 52, 86 Interestingly, the apoptotic effect of soluble galectin-1 depended upon the activation state of T cells.
Perillo and colleagues 48 clearly demonstrated that galectin-1 induced apoptosis of mature T cells bearing the CD45RO splicing product, which was found to be differentially glycosylated. 87 Although CD45 in general was found to be essential for transducing death signals generated by galectin-1, the glycosylation state of this phosphatase receptor might modulate cell susceptibility to apoptosis. This provides an alternative mechanism for explaining the immunosuppressive properties exhibited by this highly conserved protein family. Apoptosis would hence be an ideal, non-inflammatory mechanism to terminate autoimmune T-cell attack, assuring a minimum of detrimental bystander damage to the local parenchyma. 85 Regarding cell death regulation, overall opposite functions from galectin-1 have been assigned to galectin-3, providing clues to a novel paradigm. While galectin-1 has been shown to induce T-cell apoptosis, 34 ,48,52 galectin-3 has been conversely shown to prevent cell death. 49 Thus, galectins-1 and -3 may represent an additional family of proteins similar to the Bcl-2 family, where different members exhibit sequence similarity, yet opposite effects on cell survival. Whereas Bcl-2 and Bcl-X L are negative regulators of apoptosis, Bax, Bad, and Bak contribute to a positive signal in the regulation of cell death. 88 Transfection of galectin-3 cDNA into leukemia T cells conferred resistance to apoptosis induced by Fas ligation and by staurosporine. 49 Of particular interest, galectin-3 showed a significant sequence similarity to Bcl-2, mainly concentrated in the functional BH1 (NWGR) domain. Moreover, substitution of glycine to alanine in this motif completely abrogated its antiapoptotic activity. 89 It should be pointed out that the apoptotic activity of galectin-1 was demonstrated using an exogenous protein, which bound to cell surface glycoconjugates, whereas for galectin-3, the anti-apoptotic activity was shown with transfected cells in which the protein likely exerted its functions intracellularly. Moreover, other members of the galectin family may show redundancy in these pro-and anti-apoptotic effects. Indeed, it has been recently demonstrated that galectin-9, a novel tandemrepeat lectin, is able to trigger apoptosis of murine thymocytes. 90 Elucidation of the biochemical pathways and intimate mechanisms that regulate galectin-induced apoptosis will offer a remarkable opportunity to manipulate life-and-death decisions of the cells and more importantly will provide far-reaching implications for the future health of autoimmune patients. Finally, biomedical research should focus attention on other disorders associated with inhibition of apoptosis, such as cancer and viral infections and diseases associated with increased apoptosis such as neurodegenerative disorders, AIDS and ischemic injury.
Galectin-1 in activated macrophages: lethal weapon for the common good?
Macrophages (Mf) function at different levels of the immune response, either as scavenger, cytotoxic, regulatory or antigen presenting cells. 18, 91 Because galectin-1 had shown such immunomodulatory properties, we wondered whether it would be possible to identify its presence in key immunoregulatory cells, such as Mf and further prove its functional significance toward target cells.
By means of immunochemical and immunocytochemical studies, we have identified the presence of a 15 kDa soluble protein with key features of mammalian galectin-1 in rat peritoneal Mf using a polyclonal antibody raised against the extensively studied C-16 chicken isolectin. 27 The rat macrophage galectin (RMGal) was purified from chemically activated macrophages by single step affinity chromatography on a lactosyl-Sepharose matrix, resulting in the isolation of a sharp protein band of 15 kDa, an isoelectric point of 4.8 and high hemagglutinating activity specifically inhibited by saccharides bearing a b-D-galactoside configuration. 34 This protein behaved as a homodimer under nondenaturing conditions, and internal amino acid sequence revealed extensive homologies (80 ± 90%) with other members of the galectin-1 subfamily. Taken together, all of the described properties resembled those exhibited by mammalian galectin-1. Interestingly, a recent study 92 extended our findings, reporting that cell surface galectin-1-like protein was associated with complement receptor 3 (CR3), a member of the b 2 -integrin family.
Macrophages are highly adaptive cells able to modify their behavior in response to different environmental signals. 18 In this sense, resident, inflammatory or chemically-activated Mf must be viewed as distinct cell subpopulations, since they show different phenotypes according to their activation status. These up-or downregulated receptors or enzymes are closely related to their functional competence. Hence, peritoneal exudate Mf harvested after i.p. injection of inflammatory agents, such as proteose-peptone are heterogeneous in comparison to resident Mfs, which are quiescent cells, and are also distinct from Mf chemically-activated with phorbol esters or chemotactic peptides.
In the light of this observation, the next question we attempted to elucidate was related to the regulation of total and surface expression of RMGal in different Mf subpopulations. By Western blot analysis and further densitometric quantitation, we found a fivefold increase in total galectin expression in chemically activated Mf, and a twofold increase in inflammatory Mf in comparison to resident peritoneal cells (Figure 1, left panel) . Moreover, modulation of RMGal expression was accompanied by an increase in cell surface immunostaining as shown by FACS analysis of non-permeabilized cells. 27 Modulation of galectin expression and subcellular distribution validated the concept that this molecule could indeed be implicated in critical immunological processes mediated by Mf. By using current techniques to evaluate apoptosis, such as TUNEL assay, transmission electron microscopy and DNA fragmentation analysis (Figure 1, right panel) , we concluded that RMGal was clearly involved in apoptosis of mature T cells and that this effect was dependent on its carbohydrate-binding properties. 34 Several observations support the idea that cells from the monocyte-Mf lineage regulate immune function by controlling T-cell death. FasL from antigen-presenting cells was able to mediate cognate T-cell apoptosis, as shown for HIV infection. 93 Even monocytes and dendritic cells from peripheral blood of healthy individuals can induce apoptosis of mitogen-activated T cells. 93 Hence, RMGal could be seen as a lethal weapon, an alternative Mf signal to induce cell death. As galectin-3 (Mac-2 antigen) was previously found in thioglycollate-elicited Mf, 33 the interplay between these homologous proteins within the same cells should be interpreted in terms of the paradigm discussed above.
Galectins modulate different steps of the in¯ammatory cascade
That galectins could play important roles in inflammatory processes was first suggested for galectin-3, which was described as an antigen (Mac-2) expressed on the surface of thioglycollate-elicited peritoneal Mf. 33 This observation was strengthened by our findings that RMGal was differentially expressed in inflammatory and activated Mf. 27 Whatever their mechanisms of action at the molecular level, galectins are supposed to modulate inflammation acting in an autocrine or paracrine fashion.
Participation of galectins in inflammation is not limited to adhesion and migration and could be extended to the regulation of the respiratory burst and leukocyte chemotaxis. Galectin-3 has been reported to activate the NADPHoxidase and stimulate superoxide production from peripheral blood neutrophils, but only if they were pre-treated with cytochalasin B, which facilitated degranulation by disrupting the microfilament system. 50 This study has been recently undertaken by Karlsson et al, 94 who concluded that galectin-3 was able to activate NADPH oxidase in exudated but not in circulating neutrophils. Hence, galectin-3 could be viewed as a potent stimulus for the neutrophil respiratory burst, provided that the cells have previously experienced extravasation.
Galectin-3 knock out mice were also evaluated to test the effect of gene targeting toward an inflammatory challenge in a model of acute peritonitis. 95 Four days Figure 1 Galectin-1, an alternative signal in the regulation of T-cell death, is increased in activated rat macrophages. In search for mediators involved in Mfinduced T-cell apoptosis, a galectin-1-like protein (RMGal) was purified from rat peritoneal Mf and its expression was found to be differentially regulated in resident, inflammatory and activated Mf. after thioglycollate injection, galectin-3 mutant mice exhibited a reduced number of granulocytes compared to wild-type mice, suggesting that this protein could be involved in the control of acute inflammation in vivo. In the context of newly discovered galectins, ecalectin, a variant of human galectin-9, has been recently proposed as a novel eosinophil chemoattractant produced by T lymphocytes. 96 This is particularly important in terms of inflammatory diseases mediated by eosinophil accumulation, such as bronchial asthma, rhinitis and atopic dermatitis. Finally, a novel role has been recently assigned to galectin-3 in atherogenesis. 97 Since atherosclerosis is considered as an inflammatory-proliferative response of the intima layer, the striking localization of galectin-3 in carotid atherosclerotic lesions mainly in Mf and foam cells, warrants future investigation.
Galectins in embryogenesis and reproduction: a tour of the origins of life
Developmentally regulated expression of b-galactosidebinding proteins strongly suggest they could play important roles during embryogenesis. 5 Transcripts for galectins-1 and -3 were identified at early stages of embryo development, particularly at the level of the uterine wall. 29 Gene expression for both galectins was limited to trophectoderms, external structures able to make the first contact with the uterus. After gastrulation, galectins-1 and -3 did not overlap, and followed a distinct pattern of expression.
To investigate the role of these proteins during embryogenesis, knock out mice were generated 40 with targeted deletions in galectins-1 and -3. Both galectin-1 (7/7) or galectin-3 (7/7) homozygous null mutant embryos implanted successfully and newborn mice appeared to develop normally. Adult mutant mice were fertile and did not harbor any critical phenotypic difference in comparison to wild-type siblings. Several conclusions could be drawn from this experiment. At first sight, it seems that galectins-1 and -3 may be dispensable for mouse development, raising the possibility that other proteins (perhaps members of the same family), could potentially compensate for their absence, as mentioned above. Indeed, galectin-5 has also been found to be expressed at early stages of embryonic implantation. 41 Moreover, double mutant mice for galectins-1 and -3 were recently generated, but again did not show any overt abnormalities in their phenotypes. 41 Nevertheless, it is important that individual knock out mice should be carefully examined for subtle differences in other physiological systems regardless of their viability. By virtue of its implications in apoptosis, one might expect that knock out mice for galectin-1 would have autoimmune manifestations, such as lupus-like disorders, as observed in MRL lpr/lpr or C3H gld/gld mice with mutations in Fas and FasL genes respectively. 98 Transgenic mice carrying a dominant negative galectin-1 targeted to different tissues should certainly provide some clues. Recently, the only defect in galectin-1 mutant mice was revealed at the level of primary olfactory neurons, in the connections between the nasal cavity and the olfactory bulb, suggesting a role for galectin-1 in the olfactory nerve pathway. 99 Interestingly, growth retardation and early death have been reported in knock out mice for the b-1,4-galactosyltransferase enzyme, which functions by transferring galactose residues to backbone sugar structures, excellent ligands for galectins. 100 This result needs further consideration to be reconciled with the implied involvement of galectins in the regulation of programmed cell death.
Expression of apoptotic galectin-1 and mitogenic galectin-3 is differentially regulated throughout mammalian gestation. 51, 52 Galectin-3 was found to be dramatically decreased in term ovine placenta, with respect to the middle of the gestation period. In contrast, no significant decrease was observed in galectin-1 expression. Regulated expression throughout development and differential localization in the uteroplacental complex, 101 strongly imply that galectins may be critical in embryogenesis and reproduction, and justify our short trip to the origins of life.
Galectins in multistep tumor spreading: seeing the woods for the trees
Metastasis is a multistep process involving detachment of tumor cells from primary sites, angiogenesis, invasion through blood vessels into the circulation and attachment to newly colonized tissues. 102 Benefits from unraveling the wood of the metastatic cascade, will only come from a better understanding of every tree at the molecular level. Here again, endogenous galectins have been implicated in neoplastic transformation and metastasis of certain human and experimental tumors. 53 The tumorigenic potential of galectins has not been studied in such detail as their role in tumor invasion. In this sense, a critical contribution has been made by Gaudin et al, 32 who revealed that galectin-3 gene expression was upregulated by growth factors and oncogenes and downregulated by transfection of the wild-type p53 tumor suppressor gene. In the last few years, galectin-3 has been found in a wide variety of malignances such as thyroid carcinoma, 103 colon cancer 54 and tumors of the central nervous system. 104 It has been observed that the metastatic potential of mouse melanoma and fibrosarcoma correlated with the extent of galectin-3 expression on the cell surface, and that overexpression of this protein conferred an increased metastatic potential to low metastatic cells. 105 Galectin-3 probably acted by increasing the invasive potential in any step of the metastatic cascade, by virtue of its high affinity for the endothelium or its capacity to induce homotypic aggregation. 102 In most cases, increased expression of galectin-3 rendered tumor cells more invasive and was associated with a worse survival.
Regarding galectin-1, sodium butyrate increased transcription of this 14.5 kDa protein in head and neck squamous carcinoma. 30 Furthermore, this proto-type galectin has been implicated in the modulation of human melanoma cell adhesion to laminin, 62 suggesting that it could play a key role during attachment or detachment of cancer cells during tumor spreading. The contribution of other galectins to the metastatic process remains to be ascertained. Galectin-7, a marker of stratified epithelia and keratinocites has also been found to be present in human basal and spinous-cell carcinomas. 106 The possibility that the interplay between galectins-1 and -3 could be associated with control of the apoptotic threshold of cancer cells, must be considered in order to delineate novel therapeutic strategies. Strikingly, introduction of galectin-3 antisense into metastatic colon cancer cells, resulted in a significant reduction of liver colonization and spontaneous metastasis in athymic mice. 54 Finally, an attractive hypothesis is that galectin-1 expression in tumor cells (immune privileged sites) might have evolved as an apoptotic signal toward effector T cells, thus allowing tumors to escape immune attack.
Galectins in pre-mRNA splicing: a short traverse to the nucleus If almost all known glycoconjugates are localized extracellularly, why have proteins supposed to interact with carbohydrates been designed as intracellular proteins? The answer remains largely obscure. However, recent advances have contributed to clarify this issue.
Galectin-1 and -3 have been found to be associated with ribonucleoprotein (RNP) complexes in NIH3T3 fibroblasts and HeLa cells at the level of the cell nucleus. 35 These RNP complexes are designed to structurally and functionally position pre-mRNA into spliceosomes for intron removal and exon ligation during production of mature transcripts, a process called splicing. Prompted by biochemical and ultrastructural observations, Dagher et al 35 identified galectin-3 as a critical factor in pre-mRNA splicing. These observations were further extended to galectin-1. 55 Depletion of both galectins from nuclear extracts by absorption with the specific saccharide, resulted in a concomitant loss of splicing activity. Moreover, either galectin-1 or galectin-3 alone were sufficient to reconstitute, at least partially, the splicing activity of depleted nuclear extracts. These proteins appeared to act at early stages in the splicing pathway, possibly those involved in the conversion of H complexes to commitment structures. 107 Elucidation of the nuclear ligands will be critical for the understanding of this first intracellular function for galectins. A short but deep traverse to the nucleus!
Concluding remarks: Where to go? Unknown dimensions and new frontiers
Identification of homologous carbohydrate-binding proteins in lower vertebrates dates the existence of common ancestors Figure 2 Galectins participate in a wide variety of biological events involving carbohydrate recognition, such as cell adhesion, cell growth regulation, apoptosis, immunomodulation, pre-mRNA splicing, metastasis, inflammation and embryogenesis, showing in most of the cases antagonic effects. Galectin functions are susceptible to modulation according to the glycosylation state of the receptors, cell activation status, developmentally regulated expression and subcellular compartmentalization. Abbreviations: EAMG, experimental autoimmune myasthenia gravis; EAE, experimental autoimmune encephalomyelitis for the galectin gene family to more than 800 million years ago, suggesting that these endogenous lectins must be serving important biological roles. Implication of galectins in a wide variety of functions, such as cell adhesion, cell growth regulation, immunomodulation, apoptosis, embryogenesis, metastasis and pre-mRNA splicing raises exciting perspectives.
Elucidation of the molecular mechanisms involved in galectin functions will open new avenues not only at the basic level of biomedical research, but more importantly in disease diagnosis, prognosis and clinical therapy. Future research should be aimed at identifying new strategies for the treatment of autoimmune diseases, inflammatory processes, allergic reactions and tumor spreading by using recombinant galectins, synthetic peptides, neutralizing antibodies or antisense oligonucleotides.
